| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $0 ) |
| | 2024 | 2023 | VARIGEN BIOSCIENCES CORP | 3220 DEMING WAY STE 160 | MIDDLETON | WI | 53562-1498 | DANE | USA | R43CK000699 | PA-21-259, SBIR, Phase I, Rapid molecular diagnostic assay for detection of Candida auris at point of care | 01 | 1 | CDC | 2/15/2024 | $0 |
| | 2024 | 2021 | VARIGEN BIOSCIENCES CORP | 3220 DEMING WAY STE 160 | MIDDLETON | WI | 53562-1498 | DANE | USA | R43HG012181 | Novel Repair Replicase | 000 | 1 | NIH | 1/24/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $1,099,614 ) |
| | 2023 | 2023 | VARIGEN BIOSCIENCES CORPORATION | 3220 DEMING WAY STE 160 | MIDDLETON | WI | 53562-1498 | DANE | USA | R43AI174407 | Multi-Omics And Synbio Enabled Discovery Of Antifungal Fernene Triterpenes | 000 | 1 | NIH | 3/14/2023 | $300,000 |
| | 2023 | 2023 | Varigen Biosciences Corporation | 3220 Deming Way Ste 160 | Middleton | WI | 53562-1498 | DANE | USA | R43CK000699 | PA-21-259, SBIR, Phase I, Rapid molecular diagnostic assay for detection of Candida auris at point of care | 00 | 1 | CDC | 8/23/2023 | $252,235 |
| | 2023 | 2023 | VARIGEN BIOSCIENCES CORPORATION | 3220 Deming Way Ste 160 | Middleton | WI | 53562-1498 | DANE | USA | R43PS005274 | Rapid molecular diagnostic assay for detection of Hepatitis C virus at point of care | 00 | 1 | CDC | 8/30/2023 | $252,073 |
| | 2023 | 2023 | VARIGEN BIOSCIENCES CORPORATION | 3220 DEMING WAY STE 160 | MIDDLETON | WI | 53562-1498 | DANE | USA | R43AT012434 | A Universal Fungal Transposase System for Increasing Natural Product and Protein Titers | 000 | 1 | NIH | 9/5/2023 | $295,306 |
|
| Issue Date FY: 2021 ( Subtotal = $399,846 ) |
| | 2021 | 2021 | VARIGEN BIOSCIENCES CORPORATION | 505 S ROSA RD STE 15 | MADISON | WI | 53719-1262 | DANE | USA | R43HG012181 | Novel Repair Replicase | 000 | 1 | NIH | 8/10/2021 | $399,846 |
| | 2021 | 2018 | VARIGEN BIOSCIENCES CORPORATION | 3220 DEMING WAY STE 160 | MIDDLETON | WI | 53562-1498 | DANE | USA | R43HG010125 | Novel method to capture long, intact DNA for NGS applications | 000 | 1 | NIH | 2/9/2021 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $0 ) |
| | 2019 | 2017 | VARIGEN BIOSCIENCES CORPORATION | 505 S ROSA RD STE 15 | MADISON | WI | 53719-1262 | DANE | USA | R43GM123838 | High Fidelity Linear MicroVector to Clone Complex, Problematic, and Large DNAs | 000 | 1 | NIH | 5/17/2019 | $0 |
|
| Issue Date FY: 2018 ( Subtotal = $280,000 ) |
| | 2018 | 2018 | VARIGEN BIOSCIENCES CORPORATION | 505 S ROSA RD STE 15 | MADISON | WI | 53719-1262 | DANE | USA | R43HG010125 | Novel method to capture long, intact DNA for NGS applications | 000 | 1 | NIH | 7/27/2018 | $280,000 |
|
| Issue Date FY: 2017 ( Subtotal = $224,326 ) |
| | 2017 | 2017 | VARIGEN BIOSCIENCES CORPORATION | 505 S ROSA RD STE 15 | MADISON | WI | 53719-1262 | DANE | USA | R43GM123838 | High Fidelity Linear MicroVector to Clone Complex, Problematic, and Large DNAs | 000 | 1 | NIH | 4/12/2017 | $224,326 |
|
| Issue Date FY: 2006 ( Subtotal = $289,178 ) |
| | 2006 | 2006 | MEDIGEN BIOSCIENCES LLC | 505 SOUTH ROSA ROAD | MADISON | WI | 53719 | DANE | USA | R43AI065231 | POLYAMINE BASED THERAPY OF E. BIENEUSI INFECTED MICE | 000 | 1 | NIH | 5/30/2006 | $289,178 |
|
|
